These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32803637)

  • 1. Management of early breast cancer during the COVID-19 pandemic in Brazil.
    Cavalcante FP; Novita GG; Millen EC; Zerwes FP; de Oliveira VM; Sousa ALL; Freitas Junior R
    Breast Cancer Res Treat; 2020 Nov; 184(2):637-647. PubMed ID: 32803637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded Indications for Neoadjuvant Endocrine Therapy in Early-Stage Breast Cancer During the COVID-19 Pandemic.
    Khorfan R; Vora HP; Namm JP; Solomon NL; Lum SS
    Ann Surg Oncol; 2024 Oct; 31(11):7562-7568. PubMed ID: 39133445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST).
    Gasparri ML; Gentilini OD; Lueftner D; Kuehn T; Kaidar-Person O; Poortmans P
    Breast; 2020 Aug; 52():110-115. PubMed ID: 32502796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer surgery during the Covid-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of Rome.
    Pelle F; Cappelli S; Graziano F; Piarulli L; Cavicchi F; Magagnano D; De Luca A; De Vita R; Pozzi M; Costantini M; Varanese A; Panimolle M; Gullo PP; Barba M; Vici P; Vizza E; Cognetti F; Sanguineti G; Saracca E; Ciliberto G; Botti C
    J Exp Clin Cancer Res; 2020 Aug; 39(1):171. PubMed ID: 32854728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
    Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
    Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer care during a pandemic: an opportune time for cryoablation?
    Holmes DR
    Breast Cancer Res Treat; 2020 Aug; 182(3):515-521. PubMed ID: 32529409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term retrospective comparative study of the oncological outcomes of 598 very young (≤35 years) and young (36-45 years) breast cancer patients.
    Szollár A; Újhelyi M; Polgár C; Oláh E; Pukancsik D; Rubovszky G; Udvarhelyi N; Kovács T; Sávolt Á; Kenessey I; Mátrai Z
    Eur J Surg Oncol; 2019 Nov; 45(11):2009-2015. PubMed ID: 31189512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular breast cancer subtypes and therapies in a public hospital of northeastern Brazil.
    de Macêdo Andrade AC; Ferreira Júnior CA; Dantas Guimarães B; Pessoa Barros AW; Sarmento de Almeida G; Weller M
    BMC Womens Health; 2014 Sep; 14():110. PubMed ID: 25216732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Subtypes and Prognostic Factors among Premenopausal and Postmenopausal Thai Women with Invasive Breast Cancer: 15 Years Follow-up Data.
    Tubtimhin S; Promthet S; Suwanrungruang K; Supaattagorn P
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3167-3174. PubMed ID: 30486605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment patterns of elderly breast cancer patients at two Canadian cancer centres.
    Angarita FA; Chesney T; Elser C; Mulligan AM; McCready DR; Escallon J
    Eur J Surg Oncol; 2015 May; 41(5):625-34. PubMed ID: 25727372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taking a Second Look at Neoadjuvant Endocrine Therapy for the Treatment of Early Stage Estrogen Receptor Positive Breast Cancer During the COVID-19 Outbreak.
    Thompson CK; Lee MK; Baker JL; Attai DJ; DiNome ML
    Ann Surg; 2020 Aug; 272(2):e96-e97. PubMed ID: 32675509
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
    Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
    J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic.
    Papautsky EL; Hamlish T
    Breast Cancer Res Treat; 2020 Nov; 184(1):249-254. PubMed ID: 32772225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.
    Regan MM; Pagani O; Francis PA; Fleming GF; Walley BA; Kammler R; Dell'Orto P; Russo L; Szőke J; Doimi F; Villani L; Pizzolitto S; Öhlschlegel C; Sessa F; Peg Cámara V; Rodríguez Peralto JL; MacGrogan G; Colleoni M; Goldhirsch A; Price KN; Coates AS; Gelber RD; Viale G;
    Breast Cancer Res Treat; 2015 Nov; 154(2):275-86. PubMed ID: 26493064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer.
    Kurozumi S; Matsumoto H; Inoue K; Tozuka K; Hayashi Y; Kurosumi M; Oyama T; Fujii T; Horiguchi J; Kuwano H
    PLoS One; 2018; 13(8):e0201846. PubMed ID: 30080878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Receptor Status on Mastectomy and Contralateral Prophylactic Mastectomy Rates in Early Stage Invasive Breast Carcinoma.
    Dutta SW; Trifiletti DM; Grover S; Romano KD; Janowski EM; Showalter SL
    Clin Breast Cancer; 2018 Apr; 18(2):121-127. PubMed ID: 28811185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and therapy of premenopausal patients with early-onset breast cancer in Germany.
    Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Dittmer C; Wedel B; Mebes I; Diedrich K; Fischer D
    Arch Gynecol Obstet; 2012 Aug; 286(2):489-93. PubMed ID: 22491806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-Year Neoadjuvant Endocrine Therapy in Breast Cancer.
    Rusz O; Vörös A; Varga Z; Kelemen G; Uhercsák G; Nikolényi A; Ormándi K; Simonka Z; Kahán Z
    Pathol Oncol Res; 2015 Sep; 21(4):977-84. PubMed ID: 25753983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy in breast cancers.
    Masood S
    Womens Health (Lond); 2016 Sep; 12(5):480-491. PubMed ID: 27885165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.